Open access · CC-BY
via OpenAlex
The estimated prevalence and incidence of late stage age related macular degeneration in the UK
Christopher G. Owen, Zakariya A. Jarrar, Richard Wormald, Derek G. Cook, ASTRID E. FLETCHER, Alicja R. Rudnicka
British Journal of Ophthalmology · 2012 · ▲ 325 citations
Abstract
BACKGROUND: UK estimates of age related macular degeneration (AMD) occurrence vary. AIMS: To estimate prevalence, number and incidence of AMD by type in the UK population aged ≥50 years. METHODS: Age-specific prevalence rates of AMD obtained from a Bayesian meta-analysis of AMD prevalence were applied to UK 2007-2009 population data. Incidence was estimated from modelled age-specific prevalence. RESULTS: Overall prevalence of late AMD was 2.4% (95% credible interval (CrI) 1.7% to 3.3%), equivalent to 513 000 cases (95% CrI 363 000 to 699 000); estimated to increase to 679 000 cases by 2020. Prevalences were 4.8% aged ≥65 years, 12.2% aged ≥80 years. Geographical atrophy (GA) prevalence rates were 1.3% (95% CrI 0.9% to 1.9%), 2.6% (95% CrI 1.8% to 3.7%) and 6.7% (95% CrI 4.6% to 9.6%); neovascular AMD (NVAMD) 1.2% (95% CrI 0.9% to 1.7%), 2.5% (95% CrI 1.8% to 3.4%) and 6.3% (95% CrI 4.5% to 8.6%), respectively. The estimated number of prevalent cases of late AMD were 60% higher in women versus men (314 000 cases in women, 192 000 men). Annual incidence of late AMD, GA and NVAMD per 1000 women was 4.1 (95% CrI 2.4% to 6.8%), 2.4 (95% CrI 1.5% to 3.9%) and 2.3 (95% CrI 1.4% to 4.0%); in men 2.6 (95% CrI 1.5% to 4.4%), 1.7 (95% CrI 1.0% to 2.8%) and 1.4 (95% CrI 0.8% to 2.4%), respectively. 71 000 new cases of late AMD were estimated per year. CONCLUSIONS: These estimates will guide health and social service provision for those with late AMD and enable estimation of the cost of introducing new treatments.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1136/bjophthalmol-2011-301109
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Owen, C.G., Jarrar, Z.A., Wormald, R., Cook, D.G., FLETCHER, A.E., & Rudnicka, A.R. (2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. <em>British Journal of Ophthalmology</em>. https://doi.org/10.1136/bjophthalmol-2011-301109
Vancouver
Owen CG, Jarrar ZA, Wormald R, Cook DG, FLETCHER AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. British Journal of Ophthalmology. 2012. doi:10.1136/bjophthalmol-2011-301109.
BibTeX
@article{christopher2012Theest,
title = {The estimated prevalence and incidence of late stage age related macular degeneration in the UK},
author = {Christopher G. Owen and Zakariya A. Jarrar and Richard Wormald and Derek G. Cook and ASTRID E. FLETCHER and Alicja R. Rudnicka},
journal = {British Journal of Ophthalmology},
year = {2012},
doi = {10.1136/bjophthalmol-2011-301109},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Archives of Ophthalmology 2004
Open access · OA
Prevalence of Age-Related Macular Degeneration in the United States
JAMA 2004
Citation only
Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
Asia-Pacific Journal of Ophthalmology 2017
Citation only
Updates on the Epidemiology of Age-Related Macular Degeneration
Human Genomics 2025
Open access · CC-BY
Biological aging and lifespan in men and women using a Mendelian randomization study
Ophthalmology 2017
Open access · CC-BY
Prevalence of Age-Related Macular Degeneration in Europe
Archives of Ophthalmology 2011
Citation only